Fundraising FoxMaverick Ventures — 2025 Investments
9 investments dated 2025 · listed companies and verified rows first · show all
Daymark provides 24/7 in-home and virtual cancer care, offering patients an oncology-specialized team available by phone, text, video, or home visits to coordinate testing, manage symptoms and medications, and handle care logistics.
Digital HealthHealthtechMental HealthPhiladelphia, US
Justin Bekelman(Executive Officer, Director)inJonathan Rhodes(Founder)inPaul Dufault(Executive Officer)Roy Beveridge(Director)
BoardKelsey Maguire(Director)
Board seatAmbar Bhattacharyya· per SEC Form D
Co-investorsBlue Venture FundsHealthier CapitalOncology VenturesAlpha PartnersSandbox IndustriesYosemite
Tulea Health supports patients on complex medication therapies by managing care coordination and improving the medication journey.
Digital HealthHealthtechSan Francisco, US
Steve Bence(CEO)Alon Krashinsky(Executive Officer, Director)
BoardJosh Flum(Director)inAndy Mauer(Director)
Board seatAmbar Bhattacharyya· per SEC Form D
Co-investorsLRVHealth
Casium provides business immigration services combining experienced attorneys who file visas with a platform that tracks case status across 90 countries.
HR TechLegalTechSaaSBellevue, US
Priyanka Kulkarni(Founder & CEO)in
Co-investorsAllen Institute for AI (AI2) IncubatorAllen Institute for Artificial Intelligence Incubator (AI2)AI2 IncubatorFelicis VenturesGTMfund
Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOrange County, US
Alaina Brinley Rajagopal(Founder)inAditya Rajagopal(Co-founder & CEO)inYaser Abu-Mostafa(Co-founder)Lynne Rollins(Chief Financial Officer)Raymond Jimenez(Chief Technology Officer)inJeff Stoll(Chief Product Officer)in
Co-investorsBold Capital PartnersCatalyst Health VenturesFREEFLOWWavemaker Three-Sixty Health
Healthier Capital is a venture capital firm that invests in technology-enabled healthcare companies seeking to reduce costs and improve care delivery.
Digital HealthFintechHealthtech
Amir Dan Rubin(CEO and Founding Managing Partner)in
Co-investorsModi VenturesBlack Opal VenturesDefine VenturesMacquarie CapitalNorwest Venture PartnersOncology Ventures+2 more
Mandolin provides AI agents that automate back-office workflows for specialty drug administration, including patient intake, benefits verification, prior authorizations, and revenue cycle management for infusion centers and clinical practices.
AI & Machine LearningEnterprise SoftwareHealthtechSan Francisco, US
Mary Kay Huse(Founder)Will Yin(Founder)inRohit Rustagi(Founder)inRobert Meitus(Founder)
BoardMike Fitzgerald(Director)inEric Tobias(Director)in
Co-investorsGreylock PartnersSignalFireSV AngelTimeless Partners Ventures645 VenturesFoundry+1 more
Nourish provides personalized medical nutrition therapy and patient education focused on long-term behavior change.
Digital HealthHealthtechWellness & FitnessNew York City, US
Aidan Dewar(Founder)inStephanie Liu(Founder)inSam Perkins(Founder)inStaci Ketchum Cross(Executive Officer)Ana Major(Talent Acquisition Lead)Leah Nida(People \u0026 Talent Manager)
Co-investorsFLATIRONAtomicoBoxGroupElysium VenturesG SquaredHumba Ventures+11 more
.jpeg){kind=logo}
HealthtechWeston, US
Benjamin Schecter(Executive Officer, Director)
BoardLexi Henkel(Director)inAlexis Henkel(Director)
Co-investorsSpice Capital
Wild Moose builds an AI-powered on-call copilot that automates root cause analysis for production incidents, designed for engineering teams in fast-moving environments.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSNew York City, US
Yasmin Dunsky(Founder)inRoei Schuster(Founder)inTom Tytunovich(Founder)in
Co-investorsICON - Israel Collaboration NetworkMaterialized View CapitalPioneerY CombinatorF2 Venture CapitalFormulate Ventures+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.